Comparison of Pre-oxygenation of NIV and HFNC Therapy for Intubation of ICU Patients With Acute Respiratory Failure
Launched by POITIERS UNIVERSITY HOSPITAL · Jan 28, 2016
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
Design:
Clinical randomized, open, multicenter, comparative trial, with parallel groups aimed at evaluating a medical device.
Selection of patients admitted to the ICU for acute respiratory failure, requiring endotracheal intubation.
Randomized study, inclusion in two groups: NIV or HFNC.
Experimental group:
NHFC group, preoxygenation by NHFC: oxygen flow rate of 60 L / min and 100% FiO2.
Control group:
NIV group, preoxygenation by NIV: pressure support set for an exhaled tidal volume of 6-8 ml / kg of ideal body weight, PEEP of 5 cm H2O and FiO2 at 100%.
Duration of participation o...
Gender
ALL
Eligibility criteria
- Main inclusion Criteria:
- • acute hypoxemic respiratory failure requiring endotracheal intubation
- Main exclusion Criteria:
- • coma
- • NIV contraindication
About Poitiers University Hospital
Poitiers University Hospital is a leading academic medical institution dedicated to advancing healthcare through innovative clinical research and trials. As a prominent sponsor of clinical studies, the hospital leverages its multidisciplinary expertise and state-of-the-art facilities to explore new therapeutic interventions and improve patient outcomes. With a commitment to ethical standards and patient safety, Poitiers University Hospital collaborates with healthcare professionals, researchers, and institutions to facilitate groundbreaking studies that contribute to medical knowledge and enhance treatment protocols across various specialties.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Poitiers, , France
Dijon, , France
Tours, , France
Limoges, , France
Angers, , France
Strasbourg, , France
Poitiers, , France
Lille, , France
Suresnes, , France
Brest, , France
Montpellier, , France
Lyon, , France
Montauban, , France
La Rochelle, , France
Paris, , France
Colombes, , France
Paris, , France
Paris, , France
Lyon, , France
Marseille, La Timone, France
Creteil, , France
La Roche/Yon, , France
Lyon, , France
Nice, , France
Orleans, , France
Pointe à Pitre, , France
Rouen, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials